{"id":"https://genegraph.clinicalgenome.org/r/20b55182-2625-4825-8cdd-ca8e0b19b34av1.1","type":"EvidenceStrengthAssertion","dc:description":["MGAT2 was first reported in relation to MGAT2-congenital disorder of glycosylation in 1996 (Tan et al., PMID: 8808595). Seven unique variants (missense, nonsense, and frameshift) that have been reported in seven probands in six publications are included in this curation. This gene-disease relationship is also supported by two mouse models – a full gene knockout (Wang et al., PMID: 11805078, Wang et al., PMID:12417412) and a targeted knockout (Ryan et al., PMID: 24310166). In summary, there is moderate evidence to support this gene-disease relationship. While more evidence is needed to establish this relationship definitively, no convincing contradictory evidence has emerged. Of the few reports of prenatally diagnosed MGAT2-CDG, hydrops fetalis has been described in one case (PMID: 28742265) and a single case of preterm birth (PMID: 33044030) was separately reported. There is insufficient evidence to establish causation of a prenatal phenotype. This classification was approved by the ClinGen Congenital Disorders of Glycosylation GCEP on the meeting date November 7, 2024 (SOP Version 11).","MGAT2 was first reported in relation to MGAT2-congenital disorder of glycosylation in 1996 (Tan et al., PMID: 8808595). Seven unique variants (missense, nonsense, and frameshift) that have been reported in seven probands in six publications are included in this curation. This gene-disease relationship is also supported by two mouse models – a full gene knockout (Wang et al.,PMID: 11805078, Wang et al., PMID:12417412) and a targeted knockout (Ryan et al., PMID: 24310166). In summary, there is moderate evidence to support this gene-disease relationship. While more evidence is needed to establish this relationship definitively, no convincing contradictory evidence has emerged. This classification was approved by the ClinGen Congenital Disorders of Glycosylation GCEP on the meeting date November 7, 2024 (SOP Version 11)."],"dc:isVersionOf":"https://genegraph.clinicalgenome.org/r/20b55182-2625-4825-8cdd-ca8e0b19b34a","GCISnapshot":"https://genegraph.clinicalgenome.org/r/a1ff0e4d-0a54-48f3-855f-2bdb36d118db","calculatedEvidenceStrength":"Moderate","changes":{"id":"cg:summaryChange"},"contributions":[{"id":"https://genegraph.clinicalgenome.org/r/a1ff0e4d-0a54-48f3-855f-2bdb36d118db_publish_contrib","agent":"https://genegraph.clinicalgenome.org/agent/10135","date":"2025-04-02T20:40:12.018Z","role":"Publisher"},{"agent":"https://genegraph.clinicalgenome.org/agent/10106","role":"SecondaryContributor"},{"id":"https://genegraph.clinicalgenome.org/r/a1ff0e4d-0a54-48f3-855f-2bdb36d118db_contrib","agent":"https://genegraph.clinicalgenome.org/agent/10135","date":["2024-11-07T06:00:00.000Z","2024-11-07T18:00:00.000Z"],"role":"Approver"}],"curationReasons":["ErrorClarification"],"evidence":[{"id":"https://genegraph.clinicalgenome.org/r/a1ff0e4d-0a54-48f3-855f-2bdb36d118db_overall_genetic_evidence_line","type":"EvidenceLine","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/2608de0c-488f-4bdb-b2fa-4464f82b574c_proband_score_evidence_line","type":"EvidenceLine","direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/2608de0c-488f-4bdb-b2fa-4464f82b574c","type":"Proband","dc:source":"https://pubmed.ncbi.nlm.nih.gov/8808595","rdfs:label":"Tan Patient A","ageType":"AgeAtReport","ageUnit":"Years","ageValue":3,"allele":{"id":"https://genegraph.clinicalgenome.org/r/2a1805ff-0fa5-4b49-a558-21c893d24e73","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_002408.4(MGAT2):c.869C>T (p.Ser290Phe)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA254036"}},"detectionMethod":"Pharmacia ALF sequencer","firstTestingMethod":"PCR","phenotypeFreeText":"widely spaced nipples, normal deep tendon reflexes","phenotypes":["obo:HP_0001999","obo:HP_0012301","obo:HP_0003160","obo:HP_0000280","obo:HP_0001263","obo:HP_0000369","obo:HP_0001252","obo:HP_0001629","obo:HP_0012171","obo:HP_0011344"],"previousTesting":true,"previousTestingDescription":"Serum isoelectric focusing showed CDG type II pattern, fibroblasts extracts showed <2% activity of GnT II","secondTestingMethod":"Restriction digest","sex":"Female","variant":{"id":"https://genegraph.clinicalgenome.org/r/253d4b14-2f4e-4dc9-8b19-3d83b6faf852_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/8808595","allele":{"id":"https://genegraph.clinicalgenome.org/r/2a1805ff-0fa5-4b49-a558-21c893d24e73"},"alleleOrigin":{"id":"cg:GermlineAlleleOrigin"},"zygosity":{"id":"cg:Homozygous"}}},{"id":"https://genegraph.clinicalgenome.org/r/253d4b14-2f4e-4dc9-8b19-3d83b6faf852","type":"EvidenceLine","calculatedScore":1.0,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/253d4b14-2f4e-4dc9-8b19-3d83b6faf852_variant_evidence_item"},{"id":"https://genegraph.clinicalgenome.org/r/253d4b14-2f4e-4dc9-8b19-3d83b6faf852_function_evidence_item","type":"VariantFunctionalImpactEvidence","dc:description":"Sf9 cells transfected with the variant showed no GnT II activity","functionalDataSupport":"Yes"}],"specifiedBy":"GeneValidityNonNullVariantCriteria","strengthScore":1.0}],"specifiedBy":"GeneValidityMaximumProbandScoreCriteria","strengthScore":1.0},{"id":"https://genegraph.clinicalgenome.org/r/2dacef35-78d5-4428-a8bd-087cb9d52d41_proband_score_evidence_line","type":"EvidenceLine","direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/2dacef35-78d5-4428-a8bd-087cb9d52d41","type":"Proband","dc:source":"https://pubmed.ncbi.nlm.nih.gov/33044030","rdfs:label":"Poskanzer Proband","ageType":"AgeAtReport","ageUnit":"Years","ageValue":4,"allele":{"id":"https://genegraph.clinicalgenome.org/r/c8b3d067-2219-45e2-bc7f-0faa6b8bec42","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_002408.4(MGAT2):c.1006_1009del (p.Asp336LeufsTer17)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA7172629"}},"firstTestingMethod":"Homozygosity mapping","phenotypeFreeText":"hook nose, widely spaced nipples","phenotypes":["obo:HP_0001250","obo:HP_0002557","obo:HP_0001929","obo:HP_0004315","obo:HP_0002808","obo:HP_0000268","obo:HP_0003186","obo:HP_0009765","obo:HP_0001252","obo:HP_0012301","obo:HP_0011968","obo:HP_0000369","obo:HP_0000316","obo:HP_0000358","obo:HP_0031381"],"previousTesting":true,"previousTestingDescription":"Abnormal carbohydrate-deficient transferrin profile (type II), abnormal serum N-glycan profiling","secondTestingMethod":"Next generation sequencing panels","sex":"Female","variant":{"id":"https://genegraph.clinicalgenome.org/r/30d353f8-3f63-4dde-9ca7-52f1e8ef698b_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/33044030","allele":{"id":"https://genegraph.clinicalgenome.org/r/c8b3d067-2219-45e2-bc7f-0faa6b8bec42"},"alleleOrigin":{"id":"cg:GermlineAlleleOrigin"},"paternityMaternityConfirmed":"Yes","zygosity":{"id":"cg:Homozygous"}}},{"id":"https://genegraph.clinicalgenome.org/r/30d353f8-3f63-4dde-9ca7-52f1e8ef698b","type":"EvidenceLine","dc:description":"Downgraded for not expected to undergo NMD.","calculatedScore":3.0,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/30d353f8-3f63-4dde-9ca7-52f1e8ef698b_variant_evidence_item"}],"specifiedBy":"GeneValidityNullVariantCriteria","strengthScore":2}],"specifiedBy":"GeneValidityMaximumProbandScoreCriteria","strengthScore":2},{"id":"https://genegraph.clinicalgenome.org/r/5b52c4f9-0a9c-4536-8988-40f34fe3574c_proband_score_evidence_line","type":"EvidenceLine","direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/5b52c4f9-0a9c-4536-8988-40f34fe3574c","type":"Proband","dc:source":"https://pubmed.ncbi.nlm.nih.gov/8808595","rdfs:label":"Tan Patient B","ageType":"AgeAtDiagnosis","ageUnit":"Years","ageValue":9,"allele":{"id":"https://genegraph.clinicalgenome.org/r/d71a9aaf-ef4f-434b-9e50-e444ba87e3a9","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_002408.4(MGAT2):c.785A>G (p.His262Arg)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA254037"}},"detectionMethod":"Pharmacia ALF DNA sequencer","firstTestingMethod":"PCR","phenotypeFreeText":"hook nose, large dysplastic ears, thin lips, flat feet, large teeth, widely spaced nipples, normal deep tendon reflexes\ncortical atrophy","phenotypes":["obo:HP_0001250","obo:HP_0001892","obo:HP_0012448","obo:HP_0009623","obo:HP_0010990","obo:HP_0000938","obo:HP_0001629","obo:HP_0200117","obo:HP_0003160","obo:HP_0000470","obo:HP_0001263","obo:HP_0001252","obo:HP_0003423","obo:HP_0001999","obo:HP_0000369","obo:HP_0011344","obo:HP_0012171","obo:HP_0012301"],"previousTesting":true,"previousTestingDescription":"Serum isoelectric focusing - CDG type II pattern seen, fibroblast extracts showed <2% GnT II activity, no detectable GnT II in mononuclear cell extract","secondTestingMethod":"Restriction digest","sex":"Male","variant":{"id":"https://genegraph.clinicalgenome.org/r/f7a03cec-d3ac-42b0-a6f1-5de54c223275_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/8808595","allele":{"id":"https://genegraph.clinicalgenome.org/r/d71a9aaf-ef4f-434b-9e50-e444ba87e3a9"},"alleleOrigin":{"id":"cg:GermlineAlleleOrigin"},"zygosity":{"id":"cg:Homozygous"}}},{"id":"https://genegraph.clinicalgenome.org/r/f7a03cec-d3ac-42b0-a6f1-5de54c223275","type":"EvidenceLine","calculatedScore":1.0,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/f7a03cec-d3ac-42b0-a6f1-5de54c223275_variant_evidence_item"},{"id":"https://genegraph.clinicalgenome.org/r/f7a03cec-d3ac-42b0-a6f1-5de54c223275_function_evidence_item","type":"VariantFunctionalImpactEvidence","dc:description":"Sf9 cells with the variant transfected had no GnT II activity","functionalDataSupport":"Yes"}],"specifiedBy":"GeneValidityNonNullVariantCriteria","strengthScore":1.0}],"specifiedBy":"GeneValidityMaximumProbandScoreCriteria","strengthScore":1.0},{"id":"https://genegraph.clinicalgenome.org/r/0f102eea-b0af-4715-8644-d20f504e027c_proband_score_evidence_line","type":"EvidenceLine","direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/0f102eea-b0af-4715-8644-d20f504e027c","type":"Proband","dc:source":"https://pubmed.ncbi.nlm.nih.gov/33960646","rdfs:label":"Inci proband","ageType":"AgeAtDiagnosis","ageUnit":"Months","ageValue":92,"allele":{"id":"https://genegraph.clinicalgenome.org/r/50f137f8-d970-4442-918d-8433a8193e9d","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_002408.4(MGAT2):c.146del (p.Gly49ValfsTer?)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA2624726666"}},"detectionMethod":"Retrospective screening of cohort of patients who were diagnosed with CDG after molecular testing, but who did not receive a clinical or laboratory-based diagnosis.","firstTestingMethod":"Next generation sequencing panels","phenotypeFreeText":"thin lips","phenotypes":["obo:HP_0001763","obo:HP_0002240","obo:HP_0002910"],"sex":"Female","variant":{"id":"https://genegraph.clinicalgenome.org/r/75579c37-35c9-4cc5-9f3b-fcabbc51c18d_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/33960646","allele":{"id":"https://genegraph.clinicalgenome.org/r/50f137f8-d970-4442-918d-8433a8193e9d"},"alleleOrigin":{"id":"cg:AlleleOrigin"},"zygosity":{"id":"cg:Homozygous"}}},{"id":"https://genegraph.clinicalgenome.org/r/75579c37-35c9-4cc5-9f3b-fcabbc51c18d","type":"EvidenceLine","dc:description":"Reduced for consanguinity without lab testing, for very little phenotype information, and for not expected to undergo NMD. ","calculatedScore":3.0,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/75579c37-35c9-4cc5-9f3b-fcabbc51c18d_variant_evidence_item"}],"specifiedBy":"GeneValidityNullVariantCriteria","strengthScore":0.5}],"specifiedBy":"GeneValidityMaximumProbandScoreCriteria","strengthScore":0.5},{"id":"https://genegraph.clinicalgenome.org/r/743e7af3-98b9-4ae5-bd80-8321a39526b1_proband_score_evidence_line","type":"EvidenceLine","direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/743e7af3-98b9-4ae5-bd80-8321a39526b1","type":"Proband","dc:source":"https://pubmed.ncbi.nlm.nih.gov/11228641","rdfs:label":"Cormier-Daire Proband","ageType":"AgeAtDiagnosis","ageUnit":"Years","ageValue":11,"allele":[{"id":"https://genegraph.clinicalgenome.org/r/f48de5b8-f31c-4189-8320-4c235b8a4585","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_002408.4(MGAT2):c.952A>G (p.Asn318Asp)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA254038"}},{"id":"https://genegraph.clinicalgenome.org/r/2b1cdcc1-a4af-4ebf-8388-fed2c035fdd9","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_002408.4(MGAT2):c.1017T>A (p.Cys339Ter)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA254039"}}],"firstTestingMethod":"Genotyping","phenotypeFreeText":"hook nose, large teeth, thin lips, widely spaced nipples","phenotypes":["obo:HP_0000767","obo:HP_0000212","obo:HP_0001252","obo:HP_0011968","obo:HP_0001929","obo:HP_0012301","obo:HP_0002808","obo:HP_0011344","obo:HP_0003655"],"previousTesting":true,"previousTestingDescription":"Increased ASAT, decreased coagulation factors (IX, XI, protein C, protein S), abnormal PT and APT, Western blot of serum glycoproteins showed abnormal pattern, reduced N-acetylglucosaminyltransferase II activity","sex":"Male","variant":[{"id":"https://genegraph.clinicalgenome.org/r/a0f72328-8090-4861-9d09-5515a7493bae_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/11228641","allele":{"id":"https://genegraph.clinicalgenome.org/r/2b1cdcc1-a4af-4ebf-8388-fed2c035fdd9"},"alleleOrigin":{"id":"cg:GermlineAlleleOrigin"},"paternityMaternityConfirmed":"Yes","zygosity":{"id":"cg:TwoVariantsInTrans"}},{"id":"https://genegraph.clinicalgenome.org/r/5a38821e-bd63-4c5c-83dc-e3326598c68d_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/11228641","allele":{"id":"https://genegraph.clinicalgenome.org/r/f48de5b8-f31c-4189-8320-4c235b8a4585"},"alleleOrigin":{"id":"cg:GermlineAlleleOrigin"},"paternityMaternityConfirmed":"Yes","zygosity":{"id":"cg:TwoVariantsInTrans"}}]},{"id":"https://genegraph.clinicalgenome.org/r/5a38821e-bd63-4c5c-83dc-e3326598c68d","type":"EvidenceLine","calculatedScore":0.1,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/5a38821e-bd63-4c5c-83dc-e3326598c68d_variant_evidence_item"}],"specifiedBy":"GeneValidityNonNullVariantCriteria","strengthScore":0.1},{"id":"https://genegraph.clinicalgenome.org/r/a0f72328-8090-4861-9d09-5515a7493bae","type":"EvidenceLine","dc:description":"MGAT2 is a single exon gene and truncating variants are not expected to undergo NMD.","calculatedScore":1.5,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/a0f72328-8090-4861-9d09-5515a7493bae_variant_evidence_item"}],"specifiedBy":"GeneValidityNullVariantCriteria","strengthScore":1}],"specifiedBy":"GeneValidityMaximumProbandScoreCriteria","strengthScore":1.1},{"id":"https://genegraph.clinicalgenome.org/r/f70083f6-2444-4abe-b49d-3a7762463919_proband_score_evidence_line","type":"EvidenceLine","direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/f70083f6-2444-4abe-b49d-3a7762463919","type":"Proband","dc:source":"https://pubmed.ncbi.nlm.nih.gov/22105986","rdfs:label":"Alazami Proband","ageType":"AgeAtReport","ageUnit":"Years","ageValue":7,"allele":{"id":"https://genegraph.clinicalgenome.org/r/294dc51b-bb20-4fc4-a70e-cb00751e45d1","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_002408.4(MGAT2):c.711G>C (p.Lys237Asn)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA249931"}},"detectionMethod":"Homozgygosity mapping was also used in parallel","firstTestingMethod":"Exome sequencing","phenotypeFreeText":"hook nose, thin lips","phenotypes":["obo:HP_0001643","obo:HP_0012301","obo:HP_0011344","obo:HP_0000527","obo:HP_0009765"],"previousTesting":true,"previousTestingDescription":"serum isoelectric focusing showed pattern consistent with type II CDG.","secondTestingMethod":"Sanger sequencing","sex":"Male","variant":{"id":"https://genegraph.clinicalgenome.org/r/ddb0d11e-9b6d-4dff-baf2-b4418cda19eb_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/22105986","allele":{"id":"https://genegraph.clinicalgenome.org/r/294dc51b-bb20-4fc4-a70e-cb00751e45d1"},"alleleOrigin":{"id":"cg:GermlineAlleleOrigin"},"zygosity":{"id":"cg:Homozygous"}}},{"id":"https://genegraph.clinicalgenome.org/r/ddb0d11e-9b6d-4dff-baf2-b4418cda19eb","type":"EvidenceLine","calculatedScore":0.2,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/ddb0d11e-9b6d-4dff-baf2-b4418cda19eb_variant_evidence_item"}],"specifiedBy":"GeneValidityNonNullVariantCriteria","strengthScore":0.2}],"specifiedBy":"GeneValidityMaximumProbandScoreCriteria","strengthScore":0.2},{"id":"https://genegraph.clinicalgenome.org/r/d91ec982-fbe5-48e4-a674-d4dc2188c981_proband_score_evidence_line","type":"EvidenceLine","direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/d91ec982-fbe5-48e4-a674-d4dc2188c981","type":"Proband","dc:source":"https://pubmed.ncbi.nlm.nih.gov/28742265","rdfs:label":"Alsubhi Proband 1","ageType":"AgeAtReport","ageUnit":"Years","ageValue":23,"allele":{"id":"https://genegraph.clinicalgenome.org/r/294dc51b-bb20-4fc4-a70e-cb00751e45d1"},"detectionMethod":"Authors note that probands were tested either with WES or a CDG panel. The particular testing method was not noted by patient.","firstTestingMethod":"Next generation sequencing panels","phenotypes":["obo:HP_0012444","obo:HP_0000358","obo:HP_0001250","obo:HP_0001508","obo:HP_0000678","obo:HP_0001156","obo:HP_0000252","obo:HP_0001263","obo:HP_0000444"],"previousTesting":false,"previousTestingDescription":"Authors note diagnosis was confirmed with HLPC analysis of serum transferrin, but specific results were not noted.","sex":"Female","variant":{"id":"https://genegraph.clinicalgenome.org/r/e2742874-40bd-4c33-8808-c7bb18da4c98_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/28742265","allele":{"id":"https://genegraph.clinicalgenome.org/r/294dc51b-bb20-4fc4-a70e-cb00751e45d1"},"alleleOrigin":{"id":"cg:GermlineAlleleOrigin"},"zygosity":{"id":"cg:Homozygous"}}},{"id":"https://genegraph.clinicalgenome.org/r/e2742874-40bd-4c33-8808-c7bb18da4c98","type":"EvidenceLine","calculatedScore":0.2,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/e2742874-40bd-4c33-8808-c7bb18da4c98_variant_evidence_item"}],"specifiedBy":"GeneValidityNonNullVariantCriteria","strengthScore":0.2}],"specifiedBy":"GeneValidityMaximumProbandScoreCriteria","strengthScore":0.2}],"specifiedBy":"GeneValidityOverallGeneticEvidenceCriteria","strengthScore":6},{"id":"https://genegraph.clinicalgenome.org/r/a1ff0e4d-0a54-48f3-855f-2bdb36d118db_experimental_evidence_line","type":"EvidenceLine","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/a1ff0e4d-0a54-48f3-855f-2bdb36d118db_model_rescue_evidence_line","type":"EvidenceLine","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/085313bb-f569-4f9b-9316-b748a3dfdf3e","type":"EvidenceLine","calculatedScore":2,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/10fdbdea-bec4-4619-be0a-c82bdf840a30","type":"Finding","dc:description":"Knockout mice exhibited many phenotypes similar to human probands, including and most importantly N-glycosylation defects and reduced GlcNAcT-II glycosyltransferase activity.","dc:source":"https://pubmed.ncbi.nlm.nih.gov/11805078","rdfs:label":"Wang Knockout Mouse","demonstrates":{"id":"cg:ProteinAlterationDisruptsOrganismFunction"}}],"specifiedBy":"GeneValidityNonHumanModelOrganismCriteria","strengthScore":2},{"id":"https://genegraph.clinicalgenome.org/r/81725d9b-41c4-427b-b386-5d160d71510e","type":"EvidenceLine","dc:description":"Reducing due to targeted knockout and thus minimal phenotype recapitulation.","calculatedScore":2,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/44059ccc-c045-4d15-8167-7927746132f1","type":"Finding","dc:description":"Immune deficiency has been seen in one published patient with MGAT2-CDG. Reduced or absent N-glycosylation is observed in all patients.","dc:source":"https://pubmed.ncbi.nlm.nih.gov/24310166","rdfs:label":"Ryan Mouse","demonstrates":{"id":"cg:ProteinAlterationDisruptsOrganismFunction"}}],"specifiedBy":"GeneValidityNonHumanModelOrganismCriteria","strengthScore":0.5},{"id":"https://genegraph.clinicalgenome.org/r/d9292f68-e5e9-44b4-9a08-8ce392fce742","type":"EvidenceLine","dc:description":"combined with other Wang mouse model (2001) - awarding 1 more point","calculatedScore":2,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/8bae9d77-6912-42f4-a10e-2db4a1d4f047","type":"Finding","dc:description":"Knockout mice exhibited many phenotypes similar to human probands, including and most importantly N-glycosylation defects and reduced GlcNAcT-II glycosyltransferase activity.","dc:source":"https://pubmed.ncbi.nlm.nih.gov/12417412","rdfs:label":"Wang Knockout Mouse 2","demonstrates":{"id":"cg:ProteinAlterationDisruptsOrganismFunction"}}],"specifiedBy":"GeneValidityNonHumanModelOrganismCriteria","strengthScore":1}],"specifiedBy":"GeneValidityOverallModelAndRescueEvidenceCriteria","strengthScore":3.5}],"specifiedBy":"GeneValidityOverallExperimentalEvidenceCriteria","strengthScore":3.5}],"evidenceStrength":"Moderate","sequence":10169,"specifiedBy":"GeneValidityCriteria11","strengthScore":9.5,"subject":{"id":"https://genegraph.clinicalgenome.org/r/RA0hcMnXG0Q","type":"GeneValidityProposition","disease":"obo:MONDO_0008908","gene":"hgnc:7045","modeOfInheritance":"obo:HP_0000007"},"version":"1.1","websiteLegacyID":"https://genegraph.clinicalgenome.org/r/assertion_a1ff0e4d-0a54-48f3-855f-2bdb36d118db-","@context":{"@vocab":"https://genegraph.clinicalgenome.org/terms/","id":"@id","type":"@type","cg":"https://genegraph.clinicalgenome.org/terms/","dc":"http://purl.org/dc/terms/","obo":"http://purl.obolibrary.org/obo/","hgnc":"https://identifiers.org/hgnc:","rdfs":"http://www.w3.org/2000/01/rdf-schema#","cggv":"https://genegraph.clinicalgenome.org/r/gci/","evidenceStrength":{"@type":"@vocab"},"calculatedEvidenceStrength":{"@type":"@vocab"},"computedEvidenceStrength":{"@type":"@vocab"},"specifiedBy":{"@type":"@vocab"},"evidence":{"@container":"@set"},"disease":{"@type":"@vocab"},"gene":{"@type":"@vocab"},"phenotypes":{"@type":"@id"},"agent":{"@type":"@id"},"role":{"@type":"@vocab"},"modeOfInheritance":{"@type":"@vocab"},"sex":{"@type":"@vocab"},"direction":{"@type":"@vocab"},"ageType":{"@type":"@vocab"},"ageUnit":{"@type":"@vocab"},"dc:source":{"@type":"@id"},"curationReasons":{"@type":"@vocab","@container":"@set"},"GCISnapshot":{"@type":"@id"},"dc:isVersionOf":{"@type":"@id"},"websiteLegacyID":{"@type":"@id"}}}